Nuclear Renaissance

A new deal for the rare isotope Actinium-225 could break a major supply bottleneck, accelerating the development of highly targeted cancer treatments.

With $125M in new funding from steel and cement makers, newcleo accelerates its plan to turn nuclear waste into clean energy for heavy industry.